Oubari, S., Papathanasiou, M., Michel, L., Rassaf, T., Thimm, A., Hagenacker, T., . . . Carpinteiro, A. (2025). Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival. Annals of hematology, 104(3), . https://doi.org/10.1007/s00277-025-06256-7
Chicago-Zitierstil (17. Ausg.)Oubari, Sara, et al. "Gain or Amplification of 1q21 in Systemic Light Chain Amyloidosis Is Associated with Advanced Mayo Stage, Plasma Cell Disease and Worse Overall Survival." Annals of Hematology 104, no. 3 (2025). https://doi.org/10.1007/s00277-025-06256-7.
MLA-Zitierstil (9. Ausg.)Oubari, Sara, et al. "Gain or Amplification of 1q21 in Systemic Light Chain Amyloidosis Is Associated with Advanced Mayo Stage, Plasma Cell Disease and Worse Overall Survival." Annals of Hematology, vol. 104, no. 3, 2025, https://doi.org/10.1007/s00277-025-06256-7.